Scott D. RamsayMD, PhD
Dr. Ramsey is general internist and health economist. He is a Member in the Cancer Prevention Program, Division of Public Health Science at the Fred Hutchinson Cancer Research Center. He directs the Cancer Technology Assessment Group, a multidisciplinary team devoted to clinical and economic evaluations of new and existing cancer prevention, screening and treatment technologies. In addition, Dr. Ramsey is a Professor in the School of Medicine, School of Pharmacy, and the Institute for Public Health Genetics at the University of Washington. He also directs the Cancer Prevention and Survivorship Program at the Seattle Cancer Care Alliance.
Dr. Ramsey’s research focuses on economic evaluations in cancer. He has published widely on patterns of care, costs, and cost-effectiveness of treatments for lung, colorectal, and prostate cancer. His current studies—funded by the National Cancer Institute, National Human Genome Research Institute, Centers for Disease Control and Prevention, and several pharmaceutical manufacturers—include projects to develop a genetic screening policy model for colorectal cancer, a multicenter study of decision making for men with newly diagnosed prostate cancer, and studies of cancer screening, incidence, treatment, and outcomes for Native Americans diagnosed with cancer. Along with investigators at the University of Washington, Dr. Ramsey co-directs an NCI-funded training program in Biobehavioral and Cancer Outcomes Research. He is a member of the Institute of Medicine’s National Cancer Policy Forum.